Why the study?
Should advanced imaging tools replace hemodynamics as the primary approach for diagnosing, following, and managing pulmonary arterial hypertension?
Should advanced imaging tools replace hemodynamics as the primary approach for diagnosing, following, and managing pulmonary arterial hypertension?
Advanced noninvasive imaging techniques show promise in potentially replacing invasive right heart catheterization for the diagnosis and management of pulmonary arterial hypertension.
Does not support replacing invasive hemodynamics yet in pulmonary hypertension; leaves open the role of advancing noninvasive imaging pending prospective validation.
Pulmonary hypertension (PH) is currently defined based on invasive measurements: a resting pulmonary artery pressure ≥ 25 mm Hg. For pulmonary arterial hypertension, a pulmonary arterial wedge pressure ≤ 15 mm Hg and pulmonary vascular resistance > 3 Wood units are also required. Thus, right heart catheterization is inevitable at present. However, the diagnosis, follow-up, and management of PH by noninvasive techniques is progressing. Significant advances have been achieved in the imaging of pulmonary vascular disease and the right ventricle. We review the current sensitivities and specificities of noninvasive imaging of PH and discuss its role and future potential to replace hemodynamics as the primary approach to screening, diagnosing, and following/managing PH.
No takes yet. Share an insight, caveat, or question.
Gerges et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: